Unusual Indications for Cardiac Pacing

The Fifth Decade of Cardiac Pacing

Volumn , Issue , 2007, Pages 32-43

  Lau, Chu Pak ^a   Tse, Hung Fat ^a   Lee, Kathy Lai Fun ^a   Barold, S Serge ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Atrioventricular block; Cardiac pacing; Neuromuscular disease; Orthostatic hypotension; Pacemaker syndrome

Indexed keywords

EID: 84954207177     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470988404.ch3     Document Type: Chapter

References (84)

1. Glikson M, Hayes DL, Nishimura RA. Newer clinical applications of pacing. J Cardiovasc Electrophysiol 1997; 8: 1190-1203.
2. Hayes DL, Barold SS, Camm AJ et al. Evolving indications for permanent cardiac pacing. An appraisal of the 1998 ACC/AHA guidelines. Am J Cardiol 1998; 82: 1082-6.
3. Hayes DL. Evolving indications for permanent pacing. Am J Cardiol 1999; 83 (5B): 161D-165D.
4. Barold SS. New and evolving indications for cardiac pacing. In: Singer I, ed. Interventional Electrophysiology. Lippincott, Baltimore: Williams & Wilkins, 2001: 781.
5. Wolbrette DL, Naccarelli GV. Emerging indications for permanent pacing. Curr Cardiol Rep 2000; 2: 353-60.
6. Chirife R, Ortega DF, Salazar AI. 'Pacemaker syndrome' without a pacemaker. Deleterious effects of first-degree AV block [abstract]. RBM 1990; 12: 22.
7. Barold SS. Optimal pacing in first-degree AV block. Pacing Clin Electrophysiol 1999; 22: 1423-4.
8. Mabo P, Cazeau S, Forrer A et al. Isolated long PR interval as only indication of permanent DDD pacing [abstract]. J Am Coll Cardiol 1992; 19: 66A.
9. Kim YH, O'Nunain S, Trouton T et al. Pseudopacemaker syndrome following inadvertent fast pathway ablation for atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 1993; 4: 178-82.
10. Zornosa JP, Crossley GH, Haisty WK Jr et al. Pseudo pacemaker syndrome: a complication of radiofrequency ablation of the AV junction. Pacing Clin Electrophysiol 1992; 15: 590.
11. Gregoratos G, Cheitlin MD, Freedman RA et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices; a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on pacemaker implantation). J Am Coll Cardiol 1998; 31: 1175-209.
12. Tse HF, Lau CP. Long-term effect of right ventricular pacing on myocardial perfusion and function. J Am Coll Cardiol 1997; 29: 744-9.
13. Leclercq C, Gras D, Le Helloco A et al. Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. Am Heart J 1995; 129: 1133-41.
14. Rosenqvist M, Isaaz K, Botvinick EH et al. Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function. Am J Cardiol 1991; 67: 148-56.
15. Rosenqvist M, Bergfeldt L, Haga Y et al. The effect of ventricular activation sequence on cardiac performance during pacing. Pacing Clin Electrophysiol 1996: 19: 1279-86.
16. Prinzen FW, Van Oosterhout MF, Vanagt WY et al. Optimization of ventricular function by improving the activation sequence during ventricular pacing. Pacing Clin Electrophysiol 1998; 21: 2256-60.
17. Iliev II, Yamachika S, Muta K et al. Preserving normal ventricular activation versus atrioventricular delay optimization during pacing: the role of intrinsic atrioventricular conduction and pacing rate. Pacing Clin Electrophysiol 2000; 23: 74-80.
18. Barold SS. Timing cycles and operational characteristics of pacemakers. In: Ellenbogen K, Kay N, Wilkoff B, eds. Clinical Cardiac Pacing and Defibrillation, 2nd edn. Philadelphia: W. B. Saunders, 2000: 727-825.
19. Bode F, Wiegand U, Katus HA et al. Pacemaker inhibition due to prolonged native AV interval in dualchamber devices. Pacing Clin Electrophysiol 1999; 22: 1425-31.
20. Wilson JH, Lattner S. Undersensing of P waves in the presence of adequate P wave due to automatic postventricular atrial refractory period extension. Pacing Clin Electrophysiol 1989; 10: 1729-32.
21. Jaïs P, Barold SS, Shah DC et al. Pacemaker syndrome induced by the mode switching algorithm of a DDDR pacemaker. Pacing Clin Electrophysiol 1999; 22: 682-5.
22. Kuniyashi R, Sosa E, Scanavacca M et al. Pseudosindrome de marcapasso. Arq Bras Cardiol 1994; 62: 111-15.
23. Pitney M, Davis M. Catheter ablation of ventriculoatrial conduction in the treatment of pacemaker mediated tachycardia. Pacing Clin Electrophysiol 1991; 14: 1013-17.
24. Barold SS, Falkoff MD, Ong LS et al. Atrioventricular block. In: Barold SS, Mugica J, eds. New Perspectives in Cardiac Pacing 2. Mount Kisco, NY: Futura Publishing Company, 1991: 23-52.
25. Sumiyoshi M, Nakata Y, Yasuda M et al. Clinical and electrophysiologic features of exercise-induced atrioventricular block. Am Heart J 1996; 132 (6): 1277-81.
26. Luscure M, Dechandol AM, Lagorge P et al. Blocs auriculo-ventriculaires d'effort. Ann Cardiol Angeiol 1995; 44: 486-92.
27. Barold SS, Jaïs P, Shah DC et al. Exercise-induced second-degree AV block: is it type I or type II? J Cardiovasc Electrophysiol 1997; 8 (9): 1084-6.
28. Deaner A, Fluck D, Timmis AD. Exertional atrioventricular block presenting with recurrent syncope: successful treatment by coronary angioplasty. Heart 1996; 75 (6): 640-1.
29. Petrac D, Radic B, Birtic K et al. Prospective evaluation of infrahisal second-degree AV block induced by atrial pacing in the presence of chronic bundle branch block and syncope. Pacing Clin Electrophysiol 1996; 19: 784-92.
30. Runge M, Narula OS. 'Fatigue' phenomenon in the human His-Purkinje system (HPS). Circulation 1973; 48 (Suppl. IV): 103.
31. Narula OS, Runge M. Accommodation of AV nodal conduction and 'fatigue' phenomenon in the His- Purkinje system. In: Wellens HJJ, Lie KI, Janse M, eds. The Conduction System of the Heart. Leiden: Stenfert Kroese, 1976: 529-44.
32. Wald RW, Waxman MB. Depression of AV conduction following ventricular pacing. Pacing Clin Electrophysiol 1981; 4: 84-91.
33. DiLorenzo DR, Sellers D. Fatigue of the His-Purkinje system during routine electrophysiologic studies. Pacing Clin Electrophysiol 1988; 11: 263-70.
34. Sasano T, Okishige K, Azegami K et al. Transient complete atrioventricular block provoked by ventricular pacing in a patient with nonsustained ventricular tachycardia. J Electrocardiol 1999; 32: 185-90.
35. Barold SS, Barold HS. Demonstration of the fatigue phenomenon of the His-Purkinje system by right ventricular outflow tract stimulation. J Interv Card Electrophysiol 2000; 4: 489-91.
36. Englund A, Bergfeldt L, Rosenqvist M. Disopyramide stress test. A sensitive and specific tool for predicting impending high-degree AV block in patients with bifascicular block. Br Heart J 1995; 74: 650-5.
37. Englund A, Bergfeldt L, Rosenqvist M. Pharmacological stress testing of the His-Purkinje system in patients with bifascicular block. Pacing Clin Electrophysiol 1998; 21: 1979-87.
38. Mammarella A, Paradiso M, Antonini G et al. Natural history of cardiac involvement in myotonic dystrophy (Steinert's disease): a 13-year follow-up study. Adv Ther 2000; 17: 238-51.
39. Fragola PV, Autore C, Magni G et al. The natural course of cardiac conduction disturbances in myotonic dystrophy. Cardiology 1991; 79: 93-8.
40. Himmrich E, Popov S, Liebrich A et al. Hidden intracardiac conduction disturbances and their spontan-eous course in patients with progressive muscular dystrophy. Z Kardiol 2000; 89: 592-8.
41. Polak PE, Zijlstra F, Roelandt JR. Indications for pacemaker implantation in the Kearns-Sayre syndrome. Eur Heart J 1989; 10: 281-2.
42. de Meester A, Chaudron JM. Paroxysmal atrioventricular block induced during head-up tilt test. Acta Cardiol 1999; 54: 101-3.
43. Abe H, Hanada H, Kohshi K et al. Treatment of advanced atrioventricular block with beta-adrenergic blockade therapy. Pacing Clin Electrophysiol 1999; 22: 1097-9.
44. Sumiyoshi M, Nakata Y, Mineda Y. Paroxysmal atrioventricular block induced during head-up tilt testing in an apparently healthy man. J Cardiovasc Electrophysiol 1997; 8: 561-4.
45. Antonelli D, Rosenfeld T. Deglutition syncope associated with carotid sinus hypersensitivity. Pacing Clin Electrophysiol 1997; 20: 2282-3.
46. Kakuchi H, Sato N, Kawamura Y. Swallow syncope associated with complete atrioventricular block and vasovagal syncope. Heart 2000; 83: 702-4.
47. Newton JL, Allan L, Baptist M et al. Defecation syncope associated with splanchnic sympathetic dysfunction and cured by permanent pacemaker insertion. Am J Gastroenterol 2002; 96: 2276-8.
48. Baron SB, Huang SK. Cough syncope presenting as Mobitz type II atrioventricular blockaan electrophysiologic correlation. Pacing Clin Electrophysiol 1987; 10: 65-9.
49. Nakagawa S. Vagally mediated paroxysmal atrioventricular block presenting as 'Mobitz type II' block. Pacing Clin Electrophysiol 1988; 11: 471-2.
50. Lee D, Beldner S, Pollaro F et al. Cough-induced heart block. Pacing Clin Electrophysiol 1999; 22: 1270-1.
51. Seda PE, McAnulty JH, Anderson CJ. Postural heart block. Br Heart J 1980; 44: 221-3.
52. Belhassen B, Danon L, Shoshani D et al. Paroxysmal atrioventricular block triggered by orthostatic hypotension. Am Heart J 1986; 112: 1107-9.
53. Klein HO, DiSegni E, Kaplinsky E. Paroxysmal heart block triggered by sitting up. A usually undetected cause of cerebral ischemia. Heart Lung 1988; 17: 648-50.
54. Schwela H, Oltmanns G. Postural-induced complete heart block. Am Heart J 1987; 114: 1532-4.
55. Moss AJ, Glaser W, Topol E. Atrial tachypacing in the treatment of a patient with primary orthostatic hypotension. N Engl J Med 1980; 302: 1456-7.
56. Goldberg MR, Robertson RM, Robertson D. Atrial tachypacing for primary orthostatic hypotension. N Engl J Med 1980; 303: 885-6.
57. Cunha UG, Machado EL, Santana LA. Programmed atrial pacing in the treatment of neurogenic orthostatic hypotension in the elderly. Arq Brasil Cardiol 1990; 55: 47-9.
58. Kristinsson A. Programmed atrial pacing for orthostatic hypotension. Acta Med Scand 1983; 214: 79-83.
59. Weissmann P, Chin MT, Moss AJ. Cardiac tachypacing for severe refractory idiopathic orthostatic hypotension. Ann Intern Med 1992; 116: 650-1.
60. Grubb BP, Wolfe DA, Samoil D et al. Adaptive rate pacing controlled by right ventricular preejection interval for severe refractory orthostatic hypotension. Pacing Clin Electrophysiol 1993; 16: 801-5.
61. Abe H, Numata T, Hanada H et al. Successful treatment of severe orthostatic hypotension with cardiac tachypacing in dual chamber pacemakers. Pacing Clin Electrophysiol 2000; 23: 137-9.
62. Clémenty J, Gencel L, Garrigue S et al. Permanent cardiac pacing in the treatment of orthostatic hypotension: literature update and five additional cases. In: Blanc JJ, Benditt D, Sutton R, eds. Neurally Mediated Syncope. Armonk, NY: Futura Publishing Co., 1996: 127-36.
63. Mai J, Park E, Bornzin GA et al. Enhanced rate response algorithm for orthostatic compensation pacing. Pacing Clin Electrophysiol 2000; 23: 1809-11.
64. Duru F, Bloch KE, Weilenmann D et al. Clinical evaluation of a pacemaker algorithm that adjusts the pacing rate during sleep using activity variance. Pacing Clin Electrophysiol 2000; 23: 1509-15.
65. Fananapazir L, Epstein ND., Curiel RV et al. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90: 2731-42.
66. Fananapazir L, Atiga W, Tripodi D et al. Therapy in obstructive hypertrophic cardiomyopathy. The role of dual chamber (DDD) pacing. In: Barold SS, Mugica J, eds. Recent Advances in Cardiac Pacing. Goals for the 21st Century. Armonk, NY: Futura Publishing Co., 1998; 35-50.
67. Fananapazir L, McAreavey D. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. J Am Coll Cardiol 1998; 31: 259-64.
68. Kappenberger L, Linde C, Daubert C et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J 1997; 18: 1249-56.
69. Maron BJ, Nishimura RA, McKenna WJ et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (MPATHY). Circulation 1999; 99: 2927-33.
70. Nishimura RA, Trusty JM, Hayes DL et al. Dualchamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997; 29: 435-41.
71. Meisel E, Rauwolf TP, Burkhard M et al. Older patients with obstructive hypertrophic cardiomyopathy benefit most from pacemaker therapy. Results from the PIC Study. Circulation 1999; 100 (Suppl I): I-78.
72. Linde C, Gadler F, Kappenberger L. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing in Cardiomyopathy. Am J Cardiol 1999; 83: 903-7.
73. Gadler F, Linde C, Daubert C et al. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing in Cardiomyopathy. Eur Heart J 1999; 20: 1044-50.
74. Ommen SR, Nishimura RA, Squires RW et al. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. J Am Coll Cardiol 1999; 34: 191-6.
75. Gietzen FH, Leuner CJ, Hegselmann J et al. Hemodynamic effects of adjunct DDD pacing in patients with total AV block after transcoronary ablation of septum hypertrophy for hypertrophic obstructive cardiomyopathy. Circulation 1999; 100 (Suppl I): I-464.
76. Erwin JP III, Nishimura RA, Lloyd MA et al. Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a clinical perspective in 2000. Mayo Clin Proc 2000; 75: 173-80.
77. Maron BJ, Shen WK, Link MS et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 365-73.
78. Watkins H. Sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 42-3.
79. Mooe T, Rabben T, Wiklund U et al. Sleep-disordered breathing in men with coronary artery disease. Chest 1996; 109: 659-63.
80. Harbison J, O'Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000; 118: 591-5.
81. Stegman SS, Burroughs JM, Henthorn RW. Asymptomatic bradyarrhythmias as a marker for sleep apnea: appropriate recognition and treatment may reduce the need for pacemaker therapy. Pacing Clin Electrophysiol 1996; 19: 899-904.
82. Garrigue S, Bordier P, Jais P et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002; 346: 404-12.
83. Gottlieb DJ. Cardiac pacingaa novel therapy for sleep apnea? N Engl J Med 2002; 346: 444-5.
84. Kato I, Shiomi T, Sasanabe R et al. Effects of physiological cardiac pacing on sleep-disordered breathing in patients with chronic bradydysrhythmias. Psychiatry Clin Neurosci 2002; 55: 257-8.